Principal Investigator
Dr. Pachynski is an Associate Professor in the Division of Oncology at Washington University School of Medicine in St Louis. His clinical specialty is in genitourinary malignancies, with a special focus on prostate cancer. After completing an undergraduate degree in Biology at Stanford, he earned his medical degree at University of Wisconsin-Madison. During medical school, he was selected as an NIH-HHMI Research Scholar, where he worked on adoptive transfer immunotherapy in the NCI’s Surgery Branch. After returning to Stanford, he participated in the ABIM Research Pathway, completing Internal Medicine residency and fellowship in Medical Oncology. He started on faculty at Washington University School of Medicine and Siteman Cancer Center in 2014. There, he leads the prostate cancer immunotherapy program and has been involved in numerous trials and translational studies. His lab focuses on leukocyte trafficking and he has performed some of the seminal studies of the novel innate chemoattractant chemerin in cancer. He has served on American Cancer Society and NCI tumor immunology study sections, and is actively involved with SITC where he is the Chair of the Awards Committee. He serves on the editorial boards of Clinical Genitorurinary Cancer and Frontiers in Oncology. He is the recipient of both a Young Investigator Award as well as a Team Challenge Award from the Prostate Cancer Foundation, named as a Kimmel Foundation Scholar, an ACS Research Scholar, and Harrington Scholar-Innovator. He continues to lead several clinical trials and ongoing prostate translational studies, and acts as the Director of Genitourinary Oncology Research in the Division of Oncology. His lab is made up of diverse members who have a passion for science with a focus on both basic and translational immunotherapy, with an emphasis on collaborative and collegial research.